PET MRI (Positron Emission Tomography Magnetic Resonance Imaging) is a medical imaging technology that combines the high-resolution imaging capabilities of MRI with the functional imaging capabilities of PET. This technology enables the simultaneous acquisition of anatomical and functional information, making it a valuable tool in the diagnosis and management of a range of diseases.
The PET MRI market includes companies that manufacture PET MRI systems, as well as those that provide related products and services such as software and maintenance.
The global PET MRI market is slated to witness a remarkable CAGR of 9.8% between 2022 and 2029, reaching US$ 338.9 Mn by the year 2029.
PET MRI Market (2022) | US$ 176.3 Mn |
Projected Market Value (2029) | US$ 338.9 Mn |
Global Market Growth Rate (2022-2029) | 9.8% CAGR |
Share in Medical Imaging Equipment Market | 0.4% |
Request For Free Sample Report of “PET MRI Market”@ https://www.persistencemarketresearch.com/samples/28201
The market is driven by several factors, including the increasing prevalence of cancer and neurological disorders, the growing demand for hybrid imaging technologies, and the availability of advanced medical imaging systems.
The PET MRI market can be segmented based on product type, application, and end-user. Based on product type, the market can be segmented into fully integrated PET MRI systems and hybrid PET MRI systems. Based on application, the market can be segmented into oncology, neurology, cardiology, and others. Based on end-user, the market can be segmented into hospitals, diagnostic imaging centers, and others.
Companies
- AbbVie Inc. (Allergan plc)
- Eli Lilly and Company
- GlaxoSmithKline plc.
- Pfizer Inc.
- Teva Pharmaceuticals
- Bausch Health Companies Inc.
- Bayer AG
- Bristol-Myers Squibb and Company
- Sanofi S.A.
- Hoffmann-La Roche Ltd
Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/28201
The fully integrated PET MRI systems segment is expected to hold the largest share of the PET MRI market during the forecast period. This is due to the increasing adoption of fully integrated PET MRI systems in various diagnostic imaging centers and hospitals.
The oncology segment is expected to hold the largest share of the PET MRI market during the forecast period. This is due to the increasing prevalence of cancer worldwide and the growing demand for accurate and reliable diagnostic imaging technologies for cancer diagnosis and treatment.
Geographically, the PET MRI market can be segmented into North America, Europe, Asia Pacific, Middle East and Africa, and South America. North America is expected to hold the largest share of the market during the forecast period, followed by Europe and Asia Pacific. This is due to the increasing adoption of hybrid imaging technologies and the availability of advanced medical imaging systems in these regions.
Competitive Landscape
The key players are going for partnerships, collaborations, joint ventures for expanding their reach.
- Cubresa, in February 2019, did ink a distribution agreement with Worldwide Technology (S.H.) Co., Ltd. For distributing NuPET preclinical imaging products all across China, so as to improvise on research of PET MRI systems in oncology, cardiology, and neurology in China.
- The same Cubresa, in January 2019, entered into joint venture with various private investors and GaoXin Group for forming SCHERI (Sino-Canadian Health Engineering Research Institute). The basic objective was to table clinical products by making use of advanced BrainPET insert by Cubresa.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/28201
Key Segments Covered in PET MRI Market
PET MRI Market by Product Type
- Integrated
- Separate
- Insert
- Hybrid
PET MRI Market by PET Imaging Technology
- Conventional
- Time of Flight
PET MRI Market by Image Acquisition
- Sequential PET MRI Scanners
- Simultaneous PET MRI Scanners
PET MRI by Application
- Pre-clinical PET MRI Systems
- Clinical Pet MRI Systems
PET MRI Market by End-user
- Hospitals
- Diagnostic Laboratories
- Research Institutes
- Biopharmaceutical Co.
PET MRI Market by Region
- North America PET MRI Market
- Latin America PET MRI Market
- Europe PET MRI Market
- Japan PET MRI Market
- APEJ PET MRI Market
- Middle East & Africa (MEA) PET MRI Market
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Contact Us:
Persistence Market Research
United States
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com